Novem Group bought a new stake in The Allstate Co. (NYSE:ALL - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 20,041 shares of the insurance provider's stock, valued at approximately $3,864,000.
A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. VSM Wealth Advisory LLC purchased a new stake in Allstate during the 4th quarter worth about $25,000. Twin Tree Management LP acquired a new stake in shares of Allstate during the 4th quarter worth about $27,000. Vision Financial Markets LLC purchased a new stake in shares of Allstate during the fourth quarter worth about $29,000. Hopwood Financial Services Inc. purchased a new stake in shares of Allstate during the fourth quarter worth about $29,000. Finally, Kapitalo Investimentos Ltda acquired a new position in shares of Allstate in the fourth quarter valued at approximately $29,000. 76.47% of the stock is currently owned by institutional investors and hedge funds.
Allstate Price Performance
Shares of NYSE ALL opened at $208.09 on Wednesday. The company has a market capitalization of $55.11 billion, a price-to-earnings ratio of 12.25, a PEG ratio of 1.01 and a beta of 0.32. The company has a debt-to-equity ratio of 0.42, a current ratio of 0.36 and a quick ratio of 0.40. The Allstate Co. has a 1-year low of $156.66 and a 1-year high of $212.91. The business has a 50-day moving average of $199.83 and a 200-day moving average of $196.02.
Allstate (NYSE:ALL - Get Free Report) last issued its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $3.53 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.98 by ($0.45). The firm had revenue of $14.30 billion during the quarter, compared to analyst estimates of $16.41 billion. Allstate had a net margin of 7.28% and a return on equity of 28.20%. The firm's revenue was up 7.8% compared to the same quarter last year. During the same period last year, the business earned $5.13 EPS. On average, equities analysts anticipate that The Allstate Co. will post 18.74 EPS for the current fiscal year.
Allstate Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, April 1st. Shareholders of record on Monday, March 10th were given a $1.00 dividend. This is a boost from Allstate's previous quarterly dividend of $0.92. This represents a $4.00 dividend on an annualized basis and a yield of 1.92%. The ex-dividend date of this dividend was Monday, March 10th. Allstate's dividend payout ratio is presently 27.32%.
Allstate announced that its Board of Directors has authorized a stock repurchase plan on Wednesday, February 26th that allows the company to buyback $1.50 billion in shares. This buyback authorization allows the insurance provider to purchase up to 3% of its stock through open market purchases. Stock buyback plans are typically a sign that the company's board of directors believes its shares are undervalued.
Analyst Upgrades and Downgrades
Several analysts have commented on ALL shares. JPMorgan Chase & Co. lifted their target price on shares of Allstate from $217.00 to $222.00 and gave the stock an "overweight" rating in a research note on Tuesday, April 8th. Wells Fargo & Company lowered their price objective on Allstate from $200.00 to $197.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. Morgan Stanley increased their target price on Allstate from $225.00 to $235.00 and gave the stock an "overweight" rating in a research report on Tuesday, May 6th. Argus raised Allstate from a "hold" rating to a "buy" rating in a research note on Monday, March 3rd. Finally, Keefe, Bruyette & Woods upped their price objective on shares of Allstate from $228.00 to $235.00 and gave the company an "outperform" rating in a research note on Wednesday, May 7th. One analyst has rated the stock with a sell rating, one has issued a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $225.20.
View Our Latest Report on ALL
About Allstate
(
Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Further Reading
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.